The International Union of Angiology invites you to the Heparin Centennial Symposium and Workshop which will be held in Chicago on October 28 and 29.
The International Union of Angiology has always fostered the coverage of timely topics in the diagnosis and management of vascular diseases including thrombotic and bleeding disorders. The field of anticoagulation is of great interest to vascular physician and surgeons and has been a focus of basic and applied research for the past several decades. Heparin and related drugs represent one of the oldest group of drugs which have been used for medical, surgical and interventional indications. The 2016 marks the 100 years of the discovery of this important drug. The IUA has organized several scientific symposium and discussion forum for the timely coverage of important issues related to the use of heparin. The IUA has also addressed the regulatory issues and contributed to the development of guidelines and consensus documents. On the occasion of the XXVII IUA World Congress in Lyon, France several educational activities are planned. The IUA in collaboration with the North American Chapter and the Loyola University has organized a symposium to commemorate the 100 years heparin’s discovery and the progress in both clinical and scientific areas. The Scientific Committee in collaboration with the faculty of the Loyola University has worked towards the development of this important symposium.
On behalf of the Loyola University Health Sciences Division, Hemostasis and Thrombosis Research Unit, of the Departments of Pathology and Pharmacology, we are pleased to extend an invitation to you and your colleagues to join us on October 28th in a one-day international symposium dedicated to update the advances in the clinical and applied developments of heparin and related drugs. This symposium is approved for 7 CME credit hours by the Loyola University Chicago, Stritch School of Medicine, Health Sciences Division. A certificate of participation will be provided. To celebrate this landmark occasion, we have invited some of the key opinion leaders to discuss recent developments in heparin research and its clinical applications. We are enclosing the program for your review.
In addition, we have also organized a special workshop on the resourcing of heparin with developments of bovine and ovine heparins and their implications on the production of such drugs as: sulodexide, danaparoid, and other byproducts such as defibrotide. This workshop will be held on October 29th.
Registration for both events is free.
Download program and abstracts